DaVita (NYSE:DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced the acquisition of Tulips Dialysis Centre and has opened two new joint venture centers in Malaysia.
“We're very pleased to bring to Malaysia DaVita's commitment to our patients' quality of life”
"We're very pleased to bring to Malaysia DaVita's commitment to our patients' quality of life," said Dennis Kogod, chief operating officer at DaVita.
Tulips Dialysis, a hemodialysis center located in Kota Damansara, 20 kilometers east of Kuala Lumpur, has capacity for 10 stations and is currently treating patients. Medical supervision is provided by nephrologist Dr. Wong Chew Ming.
Additionally, along with joint venture partner Seri Setia Group, DaVita has opened its doors to patients at two new centers in the greater Kuala Lumpur area - a 19-station center located in central Kuala Lumpur, and a six-station center located in Rawang, Selangor.
"DaVita's expansion into Malaysia is an exciting step in the company's long-term international expansion plans," said Atul Mathur, president of Asia Pacific at DaVita.
As a leading provider of kidney care services in the United States, DaVita has achieved clinical outcomes that have improved year-over-year for more than a decade and plans to bring that track record of sustained clinical excellence to Malaysia.
Common age-associated changes in the blood found to be a risk factor for acute kidney injury